CRO undertakes First Time in Human, Phase I and POC studies in both haematological and oncological indications. These include at least HNSCC, lung, gastrointestinal, urologic, gynaecologic and breast cancer as well as haemoblastoses.
All studies are run in extensive collaboration with the Charité Departments of Haematology and Oncology (H/O), the Charité Comprehensive Cancer Centre and if requested with the Clinic for Radiation Oncology and Radiotherapy.
A Phase I Unit, embedded in the Department of H/O, a dedicated team composed of specialists in tumour diagnostics as well as therapy and our CRO Team ensure that a fully inclusive approach to early development is offered.
The following flyer illustrates how CRO can deliver optimal value in early clinical trials in the area of Haematology & Oncology. Our unique concept combines the expertise of specialised Charité departments and our dedicated study team in state-of-the art facilities: CRO oncology brochure